OraSure Technologies, Inc. develops, manufactures, markets, and sells oral fluid diagnostic products and sample collection devices in the United States, Europe, and internationally. The company is headquartered in Bethlehem, Pennsylvania.
| Revenue (TTM) | $113.02M |
| Gross Profit (TTM) | $47.77M |
| EBITDA | $-61.54M |
| Operating Margin | -78.40% |
| Return on Equity | -21.20% |
| Return on Assets | -10.60% |
| Revenue/Share (TTM) | $1.57 |
| Book Value | $4.84 |
| Price-to-Book | 0.79 |
| Price-to-Sales (TTM) | 2.20 |
| EV/Revenue | 0.745 |
| EV/EBITDA | 2.22 |
| Quarterly Earnings Growth (YoY) | 29.60% |
| Quarterly Revenue Growth (YoY) | -6.70% |
| Shares Outstanding | $68.85M |
| Float | $61.02M |
| % Insiders | 6.04% |
| % Institutions | 88.23% |
Volatility is currently expanding